Active Ingredient: VOXELOTOR
Proprietary Name: OXBRYTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N213137
Product Number: 002
Approval Date: Oct 14, 2022
Applicant Holder Full Name: GLOBAL BLOOD THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
